Casdin Capital, LLC Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$910.4B
Holdings
29
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —SPARK THERAPEUTICS INC | 940,000 | $107.0B | 11.76% | |
| 2 | 2L9BLUEPRINT MEDICINES CORP | 848,648 | $67.9B | 7.46% | |
| 3 | —MYOKARDIA INC | 1,285,000 | $66.8B | 7.34% | |
| 4 | SG7SAGE THERAPEUTICS INC | 400,000 | $63.6B | 6.99% | |
| 5 | —BLUEBIRD BIO INC | 357,500 | $56.2B | 6.18% | |
| 6 | NVTA1EURINVITAE CORP | 2,200,000 | $51.5B | 5.66% | |
| 7 | FATEFATE THERAPEUTICS INC | 2,550,000 | $44.8B | 4.92% | |
| 8 | —MAGENTA THERAPEUTICS INC | 2,643,318 | $43.5B | 4.78% | |
| 9 | BLFSBIOLIFE SOLUTIONS INC | 2,428,571 | $43.4B | 4.77% | |
| 10 | ALNYALNYLAM PHARMACEUTICALS INC | 445,000 | $41.6B | 4.57% | |
| 11 | CDXSCODEXIS INC | 2,025,000 | $41.6B | 4.57% | |
| 12 | —AUDENTES THERAPEUTICS INC | 1,010,000 | $39.4B | 4.33% | |
| 13 | SRPTSAREPTA THERAPEUTICS INC | 305,000 | $36.4B | 3.99% | |
| 14 | —GENMARK DIAGNOSTICS INC | 3,365,000 | $23.9B | 2.62% | |
| 15 | AGIOAGIOS PHARMACEUTICALS INC | 335,000 | $22.6B | 2.48% | |
| 16 | VYGRVOYAGER THERAPEUTICS INC | 1,128,075 | $21.6B | 2.37% | |
| 17 | —CONSTELLATION PHARMCETICLS I | 1,556,999 | $21.1B | 2.32% | |
| 18 | ILMNILLUMINA INC | 60,000 | $18.6B | 2.05% | |
| 19 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 300,000 | $15.9B | 1.74% | |
| 20 | 2JQGRITSTONE ONCOLOGY INC | 1,120,586 | $14.9B | 1.64% | |
| 21 | EDITEDITAS MEDICINE INC | 480,000 | $11.7B | 1.29% | |
| 22 | GBYSANGAMO THERAPEUTICS INC | 1,080,000 | $10.3B | 1.13% | |
| 23 | FIXXEURHOMOLOGY MEDICINES INC | 350,000 | $9.7B | 1.07% | |
| 24 | ONCBEIGENE LTD | 70,000 | $9.2B | 1.01% | |
| 25 | EVHEVOLENT HEALTH INC | 550,000 | $6.9B | 0.76% | |
| 26 | CDNACAREDX INC | 200,000 | $6.3B | 0.69% | |
| 27 | ALECALECTOR INC | 331,039 | $6.2B | 0.68% | |
| 28 | GILDGILEAD SCIENCES INC | 80,000 | $5.2B | 0.57% | |
| 29 | DNLIDENALI THERAPEUTICS INC | 100,000 | $2.3B | 0.26% |